Company Key Capital Corporation

Equities

Market Closed - OTC Markets Other stock markets 15:39:31 2023-05-24 EDT			5-day change	1st Jan Change
0.0001 ^USD	+900.00%		-.--%	-.--%

2020	Key Capital Corporation Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	CI
2019	Key Capital Corporation completed the acquisition of 20% stake in GoldVault.	CI

Managers	Title	Age	Since
Christopher Nichols CEO	Chief Executive Officer	-	00-12-31
Max Lupo IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Christopher Nichols CEO	Chief Executive Officer	-	00-12-31
Jennifer Reilly BRD	Director/Board Member	-	-

Key Capital Corp.

244 Fifth Avenue Suite P279

10001, New York

This company's sector is not yet available